Home > News > Details

Embarking Towards The New Era | Successful Conclusion Of The 2023 China Vitamin Industrial Summit(CVIS)

Dec 11, 2023

Embarking Towards the New Era | Successful Conclusion of the 2023 China Vitamin Industrial Summit(CVIS)

 

The 2023 China Vitamin Industrial Summit(CVIS) took place with grandeur in Hangzhou on December 7-8, 2023. Shandong New Element, as a strategic partner, had the privilege to participate in this splendid event, engaging in discussions with industry professionals, experts, and friends from various sectors on diverse aspects of vitamin industry development.

Focusing on Contemporary Issues, Addressing Real-world Questions

During the 2023 China Vitamin Industrial Summit(CVIS), experts delivered over ten thematic reports and featured speeches centering around the theme of "Key Points for the Recovery and Transformation of the Vitamin Industry." These presentations covered different perspectives, including market trends, supply chain optimization, nutritional requirements in livestock and aquaculture, and the industrialization of synthetic biology and technology. The forum aimed to provide profound insights into the industry's "timing" and "momentum," scientifically grasp market "risks" and "opportunities," and inject vitality, enhance strength, and tap into potential for the prosperous development of the vitamin industry.

The Call of the Era, the Direction of Enterprises

The summit collectively explored new directions for vitamin development, offering scientific guidance not only to accelerate the industry's new journey and promote high-quality development in the Chinese vitamin sector but also to assist enterprises in building new competitive advantages for innovation and upgrades. Numerous enterprises gathered for in-depth networking at the event.

Based on recent research and contemplation, starting from a retrospective of the vitamin industry 25 years ago to the current challenges faced by the industry, participants attempted to explore the key points for industry transformation, showcasing historical regression and ecological development.

In 1998, before six overseas vitamin companies faced antitrust lawsuits, global production of both vitamin monomers and multivitamins was largely monopolized by foreign manufacturing companies.

 

Table 1: 1998 Global Major Vitamin Producers

news-554-203

*Including other nutritional or fine chemical products

 

At that time, almost all vitamin production enterprises were primarily engaged in chemical and pharmaceutical industries. Even the so-called global vitamin giants Roche, BASF, and Rhone-Poulenc were top pharmaceutical and chemical enterprises. Although they were the world's largest producers of multivitamins at the time, the revenue from their vitamin-related sectors (including fine chemicals) accounted for only 10% to 20% of the total company revenue.

Apart from the three giants, all other pharmaceutical or chemical companies producing vitamins at that time only produced 1-3 types of vitamin monomers.

In 1999, antitrust actions against vitamins in the United States and Europe completely broke the global vitamin market monopoly, leading to a significant decline in the profits of the three major companies. They underwent a series of asset and corporate restructurings. Roche sold its vitamin business to DSM, focusing on pharmaceuticals; Adisseo became independent from Rhone Poulenc and became an animal nutrition company, while the remaining chemical part formed Aventis SA with part of Hoechst at that time; BASF sold its vitamin premix business in eight countries to Dutch DSM in 2007, causing a major shift in the global market landscape.

During this process, a group of Chinese pharmaceutical and fine chemical companies began to enter the production of vitamin monomers. Utilizing continuous technological innovation, the rapid development of the domestic market, the opportunities for the globalization of the Chinese industry, and the push from later-stage capital inflows, China's vitamin industry experienced significant growth and expanded into the global market.

 

news-557-251

Figure 1: Transfer of Global Vitamin Production Capacity in the Past 25 Years (1998-2023)

 

In this process, a group of leading Chinese enterprises in the vitamin industry emerged, including both comprehensive enterprises and those specializing in specific products.

 

Table 2: Leading Listed Companies in the Chinese Vitamin Industry

news-542-240

Unit: RMB (A-share listed), with Pharmaceutical Group in Hong Kong (Hong Kong-listed) in RMB billion (Data source: public data from the securities market)

 

This includes Xinfuda Pharmaceutical, which produces calcium pantothenate, vitamin B6, vitamin A, and folic acid monomers; Shandong New Element Biotechnology, a technology innovation enterprise specializing in high-concentration and high-purity natural vitamin E, established in 2015.; Ruibang, which produces niacinamide; and Yuxing Group, which produces vitamin B12.

In the past decade, capital-driven redundant construction and expansion of production capacity have led to an increasingly severe oversupply situation. Compared to the overall operating rate of 85%-97% in 2015, the overall operating rate of vitamin monomers in 2023 is only slightly above 60%.

In the last three years, as Chinese vitamin enterprises faced intense competition and weak downstream demand, the redundant construction and expansion of production capacity led to a significant decrease in profits, with some companies experiencing losses.

 

Table 3: Changes in Earnings of Listed Vitamin Companies from 2019 to 2023

news-562-272

(Data source: annual reports of various listed companies)

 

According to Shandong New Element's research and analysis, based on the historically low prices of products in 2023, most products experienced varying degrees of losses.

 

Table 4: Continuous Expansion of Vitamin Production Capacity, Diversification of Industry Concentration, and Expansion of Industry Losses

1

 

Grasping the Pulse of the Times, Firm Confidence in Development

The entire vitamin industry has entered a severe winter, facing challenges both internally and externally. In this challenging environment, enterprises in the industry must make relevant decisions and adjustments to break through the current deadlock, promote the fission and recovery of the vitamin industry while ensuring their own survival and development.

The era creates opportunities and entrusts responsibilities. In the current industrial transformation, countless enterprises are contributing their unique strengths. Shandong New Element, as a smart service platform in the feed industry, promotes the integration of digital technology, the internet, and the feed industry, building an innovative ecosystem with industry linkage, spatial connection, and functional integration. This gives rise to new formats and models in the feed industry.

The conference has concluded, and Shandong New Element will continue to adhere to innovation, helping enterprises continuously optimize the business ecological environment. Shandong New Element hopes to join hands with more partners, empowering the industry's sustainable development with smart technology while facilitating the high-quality development of the industry through innovation.